InvestorsHub Logo
icon url

curiousbuild

09/20/14 2:10 PM

#258 RE: ebota12 #257

I wouldn't think Mike would give full disclosure on MMPR progress via email..

What he said in e-mail doesn't make sense with his tweet, from August 29th



Additionally, crew was in Montreal and Quebec two weeks ago. There must be a reason they gathered there, and another lawyer addition is from Quebec. The lawyer is for lobbying with French speaking bureaucrats when it's needed and be second arm to Manny in Ottawa.

Mike is not giving full details for sure.

There was a mistake on my streamer and google regarding S/S on Sep 11th, Mike confirmed same day that there was no change on S/S and it was mistake.

He was truthful as I saw S/S corrected on my streamer a week later..and recent filing confirms it too. Mike is honest person but I think he doesn't wanna give any info on MMPR progress.

There is only one applicant from Mission,BC on HC filings and that's gotta be Experion for sure. Plus experion applied more than a year ago. Biocell and Experion should have licenses soon when you put all things together since early year.

If his e-mail is the case, things don't look good for another year and I don't think he can be that much behind..

AND an article from chris parry again Sept 9th

In happier news, I'm hearing a lot of online talk that Abattis Bioceuticals (CSE:C.ATT, Stock Forum) has a license announcement coming soon. You sometimes here this kind of talk and it can quickly take a life of its own online, where rumour is enough to get some in a buying state of mind. But I have to say I've heard from people who are connected to the company that their gears are well and truly turning right now. I don’t know specifics, but I know management is very smiley right now.

UPDATE: Abattis’ Phytalab unit just announced it has lab certification in Washington State to provide cannabis analysis laboratory services to the industry. Stock up 5.5%.

Abattis CEO Mike Withrow said in a news release, "This is one more milestone the team has achieved in building our overall plan. In addition to revenue, having a licensed lab will serve as a core competency in the Abattis group of companies that collects and stores a bank of tissue culture and logs invaluable data that can be repurposed within the Abattis group of companies and with strategic partners licensed to work with cannabis."

Abattis had the early run in the stage 1 weed explosion early this year, but drifted when it went through a period of quiet solidification while other companies started making grand promises of world domination.

If you look deeply at the extensive vertical integration lineup that Abattis has put together, it's a compelling story. Certainly still in my top 5. And this is a great demonstration of their plan in action.
Read more at http://www.stockhouse.com/news/newswire/2014/09/08/medical-marijuana-update-organigram-s-ipo-success-points-to-thunder-coming#45PhzaEmkvyfFqLG.99


ANyways, I hope he comes up with some solid catalyst as I predict more downtrend for us. All of their stock options are joke now at this point, they are all down as well and not selling single share since April.

http://www.cnsx.ca/cmsAssets/docs/Filings/2014/2014_08_13_20_18_36_ATT_Form_11.pdf

Float is still tight and I have no doubt this pps will raise fast with solid update from company.

We all had different reasons to buy and sell early in the year, but right now I don't see a reason to buy or sell. And I am sure new investors think same way as there are other Canadian plays with "more potential" of ROI.





icon url

cj 13

09/20/14 5:50 PM

#263 RE: ebota12 #257

If you dig out one of my other posts in another email exchange they are selling biocubes. He said they sold 4. Maybe they are going to sell biocube to that buffet subsidiary that is going to do the same thing lol.. idk oh and yes he answered specifically with a no, then proceeded to blue sky it a bit. Does sound like they are working on something tho.